Coherus attempts to dismiss Amgen’s Neulasta suit

12-06-2017

Coherus attempts to dismiss Amgen’s Neulasta suit

AVNphotolab / iStockphoto.com

Coherus BioSciences has asked a court to dismiss patent infringement allegations brought against it by Amgen.


Coherus BioSciences, Amgen, Neulasta, BPCIA, FDA, biosimilar, patent, patent infringement

LSIPR